Private Equity 3 Days

Last updated: May 27, 2026, 8:30 AM ET

Deal Activity & Sector Pushes Backed a $1.3bn royalty and debt package as Blackstone Life Sciences teamed with Apogee Therapeutics, signaling deepening biotech financing even as the sector wrestles with higher capital costs. At the same time, invested in payments‑tech firm Amusement Connect and backed loyalty‑rewards provider Patron Points illustrate how mid‑market PE firms are targeting high‑margin Saa S niches that benefit from recurring revenue models. The parallel moves underscore a broader trend of capital chasing scalable software that can lock in long‑term fees, a dynamic that helped drive overall PE deal volume higher in the past week.

Geographic Expansion & Credit Strategies Prepared a public‑private credit fund for Asia as KKR and Capital Group aim to replicate their U.S. hybrid‑credit franchise across the region, reflecting growing investor appetite for flexible financing amid tighter bank lending. Complementing that, committed up to $1bn for a U.S. AI‑inference data‑centre platform shows I Squared Capital betting on the infrastructure needs of generative‑AI workloads, a niche that is rapidly attracting sovereign and institutional capital. Both initiatives highlight private capital’s pivot toward credit‑oriented products that can capture yield in an environment of lingering rate uncertainty.

Large‑Scale Exits & Fundraising Milestones Exited a €4bn stake in Spain’s Naturgy after an eight‑year hold, delivering a headline‑making cash return for CVC Capital Partners and reinforcing the firm’s reputation for timing exits in the utility sector. Meanwhile, CPP Investments reported assets of C$793.3bn, a 10.9% rise year‑on‑year, with private‑equity allocations now representing 22% of the portfolio, indicating that sovereign investors continue to lean heavily on PE for growth and diversification. In Europe, Eurazeo’s Elevate team secured more than €1bn at the first close of its fifth mid‑market buyout vintage, matching the size of the prior fund and confirming strong LP confidence despite macro headwinds.

Strategic Acquisitions & Platform Consolidations Acquired rights‑and‑royalties software Rightsline for $500m as Hg deepens its presence in the IP‑management niche, a sector that has seen heightened M&A activity due to rising demand for transparent royalty tracking. Similarly, EQT moved to become the majority owner of the merged EV‑charging platform Voltera‑Revel, while retaining a minority stake for BlackRock’s GIP, positioning the firm to benefit from the accelerating electrification of transport. These platform‑building plays illustrate how PE sponsors are consolidating fragmented technology assets to create scale and cross‑sell services.

Take‑Private Bids & Sector‑Specific Targets Launched a $2.02bn take‑private offer for Bodycote, a FTSE‑250 heat‑treatment specialist, reflecting Apollo Global Management’s confidence that industrial services can be upgraded through operational improvements and digital tooling. In a parallel move, Permira agreed to an A$3.4bn exit from I‑MED Radiology, while Bowmark and Bridgepoint prepared to sell Helio Intelligence, underscoring private equity’s continued focus on high‑margin, data‑rich health‑tech businesses that can leverage AI for diagnostic efficiency. These transactions suggest that sponsors are targeting sectors where technology can unlock cost savings and new revenue streams.

Liquidity Management & Risk Transfer Explored shedding $4bn of NAV loan exposure as JPMorgan seeks to offload risk tied to private‑equity fund financing, a move that may tighten credit conditions for leveraged buyouts if banks retreat from such loans. The shift comes as LPs demand greater transparency and risk mitigation after recent market turbulence, reinforcing the importance of secondary‑market solutions and structured credit products in the PE ecosystem.